What to do about primary-prevention implantable cardiac defibrillators in patients with improved ejection fraction

Niyada Naksuk, Selcuk Adabag

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations

Abstract

Approximately 20-40% of heart failure patients with reduced ejection fraction (EF) demonstrate substantial improvements in their EF during follow-up. A subset of these patients who had originally received implantable cardioverter defibrillators (ICD) for the primary prevention of sudden cardiac death (i.e., patients with EF<35%) pose a challenge to cardiologists when they present with improvements in EF to above 35% at the time of their battery depletion. Little is known about the risk of sudden cardiac death in these patients. Is the risk high enough to warrant the replacement of the ICD generator? In the following article, we review the available data on the risk of sudden cardiac death in these patients, and aim to assist the clinician and the patient in making informed decisions about whether the ICD therapy should be continued.

Original languageEnglish (US)
Pages (from-to)197-200
Number of pages4
JournalCurrent heart failure reports
Volume11
Issue number2
DOIs
StatePublished - Jun 2014
Externally publishedYes

Keywords

  • Battery depletion
  • Elective replacement indicator (ERI)
  • Generator replacement
  • Heart failure
  • Implantable cardioverter defibrillator
  • Preserved ejection fraction
  • Primary prevention
  • Recovered ejection fraction
  • Sudden cardiac death
  • Ventricular arrhythmias

ASJC Scopus subject areas

  • Emergency Medicine
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Fingerprint Dive into the research topics of 'What to do about primary-prevention implantable cardiac defibrillators in patients with improved ejection fraction'. Together they form a unique fingerprint.

Cite this